The transwell assay showed that, in comparison to the Control-EV group, EGR1 overexpression significantly decreased the migration and invasion of ccRCC cells (p < 0.01) (Fig. 4C,D). Here, EGR1 is linked to nonpapillary renal cell carcinoma.